• Who-we-are-banner

    News

Charles Russell Speechlys advises Biolog-id on the execution of a Business Combination Agreement for proposed $312 million merger

Charles Russell Speechlys Paris has advised Biolog-id on the negotiation of a Business Combination Agreement ("BCA") relating to a proposed merger between Biolog-id and Genesis Growth Tech Acquisition Corp, a Nasdaq-listed special purpose acquisition company ("SPAC").

Biolog-id is a global leader in the development and service of identification and traceability solutions for blood products and injectable therapeutic preparations in oncology. The merger will create a publicly traded digital health solutions company focused on value chain optimisation.

The transaction values Biolog-id at $312 million and is expected to close in the first quarter of 2023. Following the merger, Biolog-id will be listed on Nasdaq under the symbol "BGID”.

Renaud Ferry, Partner, comments: “We are pleased to have advised Biolog-id on a key part of their digital health strategy as they advance their capabilities in value chain optimisation for blood products and other biologics. Our team, based in the Firm’s Paris office, worked alongside a number of law firms across multiple jurisdictions to achieve this result.”

The Charles Russell Speechlys team was led by Partner Renaud Ferry, with support from Associates, Pierre-Adrien Mayot and Orlando Vignoli Neto.

Overall the transaction involved eight firms including Allen & Overy LLP, Linklaters, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., Carey Olsen, RSM France, O'Melveny & Myers LLP and Conyers Dill & Pearman LLP, across three jurisdictions.

Our thinking

  • Charles Russell Speechlys advises Foodles on the strategic acquisition of caterer Le Val d'Evre

    Renaud Ferry

    News

  • Ultimate Beneficial Ownership

    William Reichert

    Insights

  • Consumer Duty Board Report

    Richard Ellis

    Insights

  • ESG Reporting for Public and Listed Companies

    William Reichert

    Insights

  • Renewable Energy

    William Reichert

    Insights

  • Is the horizon level? Current updates and predictions for Competition Law in the UAE

    William Reichert

    Insights

  • The Use of Experts in International Arbitration

    Peter Smith

    Insights

  • The Digital Markets, Competition and Consumers Act receives Royal Assent! What can we expect to see in consumer law changes?

    Dillon Ravikumar

    Insights

  • Charles Russell Speechlys advises on the acquisition of Wycombe Wanderers Football Club

    Keir Gordon

    News

  • Charles Russell Speechlys advises long standing client AgDevCo on its equity investment in Agris

    Adrian Mayer

    News

  • The Guardian and City AM quote Ashwin Pillay on Anglo American rejecting a second takeover bid from BHP

    Ashwin Pillay

    In the Press

  • Charles Russell Speechlys advises CLA UK on the acquisition of Engine B

    Charlie Ring

    News

  • ESG due diligence in private company M&A

    Megan Gray

    Insights

  • A Guide to Arbitrability in International Arbitration

    Peter Smith

    Insights

  • DIFC Courts Release 2023 Annual Report

    Peter Smith

    Quick Reads

  • Takeover Panel consults on narrowing the scope of the Takeover Code

    Jodie Dennis

    Insights

  • James Broadhurst writes for the Financial Times’ Your Questions column on inheriting company shares

    James Broadhurst

    In the Press

  • Charles Russell Speechlys bolsters corporate and commercial offering with the appointment of Shirley Fu in Hong Kong

    Shirley Fu

    News

  • Charles Russell Speechlys advises Give Back Beauty Group in the acquisition of INCC Parfums

    Dimitri A. Sonier

    News

  • Planning and Life Sciences: the challenges and opportunities in the Golden Triangle

    Sophie Willis

    Quick Reads

Back to top